- Home
- GV vs RDHL Comparison
GV vs RDHL Comparison
Compare GV & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GV | RDHL |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 3.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GV | RDHL |
|---|---|---|
| Price | $1.20 | $1.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 49.5K | ★ 62.9K |
| Earning Date | 01-13-2026 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,773,905.00 | ★ $9,550,000.00 |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 157.62 |
| 52 Week Low | $1.02 | $1.01 |
| 52 Week High | $9.60 | $6.98 |
Technical Indicators
Market Signals| Indicator | GV | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 34.58 | 33.88 |
| Support Level | $1.12 | $1.10 |
| Resistance Level | $1.35 | $1.23 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 33.33 | 0.00 |
Price Performance
Historical ComparisonAbout GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.